Venture capital in Europe is pouring into artificial intelligence while women‑focused health technology—femtech—struggles to attract funding. The AI boom has led to a sharp decline in femtech investment, leaving startups that address endometriosis, menopause, fertility and maternal health under‑funded. Industry leaders warn that this imbalance could widen health gaps for women and hinder Europe's historical leadership in health innovation. Calls are growing for investors and policymakers to rebalance capital toward femtech, ensuring that women’s health receives the attention and resources it needs alongside AI development.
Leia mais → 
